As a holder of both, I'd say they are both still undervalued. I love the science - AVR has replicated a human valve with amazing results - and IMU look like they may have solved part of the puzzle to cure solid tumours, with incredible early results on low doses.
But that is the game - how do you accurately price potential - especially in a market where the big players use all the tricks at their disposal in an attempt to distort pricing in order to make their quarterly/monthly targets?
Pre-revenue stocks are probably never 'actual' fair value, whether it's FOMO to the upside or underappreciated and unloved to the downside - but that is where the opportunities are IMO, all hail the patient investor!
AVR will have it's day again! Good luck all.
TAVR MARKET Superiority, page-40
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.69 |
Change
0.090(0.48%) |
Mkt cap ! $359.2M | |||
| Open | High | Low | Value | Volume |
| $18.62 | $18.70 | $18.45 | $130.9K | 7.041K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $18.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.90 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |